Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis. J Clin Endocrinol Metab. 2016;101:2826–35.

Article  PubMed  Google Scholar 

Burrello J, Monticone S, Losano I, Cavaglià G, Buffolo F, Tetti M, et al. Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension 2020;75:1025–33.

Article  CAS  PubMed  Google Scholar 

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: A multicenter study in Japan. Hypertension 2018;71:530–7.

Article  CAS  PubMed  Google Scholar 

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, et al. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol. 2019;181:339–50.

Article  CAS  PubMed  Google Scholar 

Buffolo F, Tetti M, Mulatero P, Monticone S. Aldosterone as a mediator of cardiovascular damage. Hypertension 2022;79:1899–911.

Article  CAS  PubMed  Google Scholar 

Murata M, Kitamura T, Tamada D, Mukai K, Kurebayashi S, Yamamoto T, et al. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. J Hypertens. 2017;35:1079–85.

Article  CAS  PubMed  Google Scholar 

Kario K, Shin J, Chen CH, Buranakitjaroen P, Chia YC, Divinagracia R, et al. Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network. J Clin Hypertens (Greenwich). 2019;21:1250–83.

Article  PubMed  Google Scholar 

Shintani Y, Kikuya M, Hara A, Ohkubo T, Metoki H, Asayama K, et al. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens. 2007;25:1704–10.

Article  CAS  PubMed  Google Scholar 

Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007;50:325–32.

Article  CAS  PubMed  Google Scholar 

Kario K. Nocturnal Hypertension: New Technology and Evidence. Hypertension 2018;71:997–1009.

Article  CAS  PubMed  Google Scholar 

Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet 2007;370:1219–29.

Article  PubMed  Google Scholar 

Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–5.

Article  CAS  PubMed  Google Scholar 

Yano Y, Inokuchi T, Hoshide S, Kanemaru Y, Shimada K, Kario K. Association of poor physical function and cognitive dysfunction with high nocturnal blood pressure level in treated elderly hypertensive patients. Am J Hypertens. 2011;24:285–91.

Article  PubMed  Google Scholar 

Yano Y, Ning H, Muntner P, Reis JP, Calhoun DA, Viera AJ, et al. Nocturnal blood pressure in young adults and cognitive function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Hypertens. 2015;28:1240–7.

Article  PubMed  PubMed Central  Google Scholar 

Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16:434–8.

Article  PubMed  Google Scholar 

Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, et al. Nighttime blood pressure phenotype and cardiovascular prognosis: Practitioner-based nationwide JAMP study. Circulation 2020;142:1810–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Middeke M, Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Bmj 1994;308:630–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ceruti M, Petramala L, Cotesta D, Cerci S, Serra V, Caliumi C, et al. Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens (Greenwich). 2006;8:642–8.

Article  PubMed  Google Scholar 

Middeke M, Klüglich M, Holzgreve H. Circadian blood pressure rhythm in primary and secondary hypertension. Chronobiol Int. 1991;8:451–9.

Article  CAS  PubMed  Google Scholar 

Wu Q, Hong M, Xu J, Tang X, Zhu L, Gao P, et al. Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism. Endocrine 2021;72:835–43.

Article  CAS  PubMed  Google Scholar 

Penzo M, Palatini P, Rossi GP, Zanin L, Pessina AC. In primary aldosteronism the circadian blood pressure rhythm is similar to that in primary hypertension. Clin Exp Hypertens. 1994;16:659–73.

Article  CAS  PubMed  Google Scholar 

Mansoor GA, White WB. Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism. Hypertension 1998;31:843–7.

Article  CAS  PubMed  Google Scholar 

Libianto R, Menezes S, Kaur A, Gwini SM, Shen J, Narayan O, et al. Comparison of ambulatory blood pressure between patients with primary aldosteronism and other forms of hypertension. Clin Endocrinol (Oxf). 2021;94:353–60.

Article  CAS  PubMed  Google Scholar 

Azushima K, Tamura K, Haku S, Wakui H, Kanaoka T, Ohsawa M, et al. Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: A multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2). Atherosclerosis 2015;240:297–304.

Article  CAS  PubMed  Google Scholar 

Yanagi M, Tamura K, Fujikawa T, Wakui H, Kanaoka T, Ohsawa M, et al. The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease. Hypertens Res. 2013;36:262–9.

Article  CAS  PubMed  Google Scholar 

Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, et al. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens. 2007;29:31–42.

Article  CAS  PubMed  Google Scholar 

Azushima K, Wakui H, Uneda K, Haku S, Kobayashi R, Ohki K, et al. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease. Clin Exp Hypertens. 2017;39:665–71.

Article  PubMed  Google Scholar 

Mitsuhashi H, Tamura K, Yamauchi J, Ozawa M, Yanagi M, Dejima T, et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis 2009;207:186–90.

Article  CAS  PubMed  Google Scholar 

Masuda S, Tamura K, Wakui H, Kanaoka T, Ohsawa M, Maeda A, et al. Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy. Hypertens Res. 2009;32:950–5.

Article  CAS  PubMed  Google Scholar 

Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, et al. New diagnostic criteria of adrenal subclinical Cushing’s syndrome: Opinion from the Japan Endocrine Society. Endocr J. 2018;65:383–93.

Article  CAS  PubMed  Google Scholar 

Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327–59.

Article  PubMed  Google Scholar 

Nanba AT, Nanba K, Byrd JB, Shields JJ, Giordano TJ, Miller BS, et al. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol (Oxf). 2017;87:665–72.

Article  CAS  PubMed  Google Scholar 

Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126–48.

Article  PubMed  Google Scholar 

Zelinka T, Widimský J. Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronism. Physiol Res. 2001;50:51–57.

CAS  PubMed  Google Scholar 

Takakuwa H, Shimizu K, Izumiya Y, Kato T, Nakaya I, Yokoyama H, et al. Dietary sodium restriction restores nocturnal reduction of blood pressure in patients with primary aldosteronism. Hypertens Res. 2002;25:737–42.

Article  CAS  PubMed  Google Scholar 

Bollag WB. Regulation of aldosterone synthesis and secretion. Compr Physiol. 2014;4:1017–55.

Article  PubMed  Google Scholar